Johnson & Johnson (NYSE:JNJ)
Barclays Global Healthcare Conference 2017
March 14, 2017 08:30 AM ET
Executives
Jennifer Taubert - Group Chairman, Pharmaceuticals, The Americas
Joseph Wolk - Vice President, Investor Relations
Analysts
Geoff Meacham - Barclays
Geoff Meacham
Good morning. Welcome to the first morning session for the Barclays Global Healthcare Conference. My name is Geoff Meacham. I'm the Senior Biopharma Analyst here, and also Paul is here with my team on the stage with me as well. And today we have Johnson & Johnson, and speaking on behalf of Johnson & Johnson is Group Chairman for Pharmaceuticals for the Americas, Jennifer Taubert, welcome; and also Joe Wolk from the Investor Relations teams. So, he will kick it off with high a level discussion on -- you want to talk about just opening remarks on the pharma business. We'll get into some questions, but Joe if you want to first do this for us here.
